FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:

Size: px
Start display at page:

Download "FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:"

Transcription

1 Natinal Imaging Assciates, Inc. Clinical guideline CT HEART CT HEART Cngenital (Nt including crnary arteries) Original Date: September 1997 Page 1 f 10 CPT Cdes: 75572, Last Reviewed Date: September 2014 NCD Last Effective Date: March 2008 Guideline Number: NIA_CG_025 Last Revised Date: February 2015 Respnsible Department: Clinical Operatins Implementatin Date: February 2015 FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY: Item/Service Descriptin A. General Diagnstic examinatins f the head (head scans) and f ther parts f the bdy (bdy scans) perfrmed by cmputerized tmgraphy (CT) scanners are cvered if medical and scientific literature and pinin supprt the effective use f a scan fr the cnditin, and the scan is: (1) reasnable and necessary fr the individual patient; and (2) perfrmed n a mdel f CT equipment that meets the criteria in C belw. CT scans have becme the primary diagnstic tl fr many cnditins and symptms. CT scanning used as the primary diagnstic tl can be cst effective because it can eliminate the need fr a series f ther tests, is nn-invasive and thus virtually eliminates cmplicatins, and des nt require hspitalizatin. Indicatins and Limitatins f Cverage fr NCD B. Determining Whether a CT Scan Is Reasnable and Necessary Sufficient infrmatin must be prvided with claims t differentiate CT scans frm ther radilgy services and t make cverage determinatins. Carefully review claims t insure that a scan is reasnable and necessary fr the individual patient; i.e., the use must be fund t be medically apprpriate cnsidering the patient's symptms and preliminary diagnsis. There is n general rule that requires ther diagnstic tests t be tried befre CT scanning is used. Hwever, in an individual case the cntractr's medical staff may determine that use f a CT scan as the initial diagnstic test was nt reasnable and necessary because it was nt supprted by the patient's symptms r cmplaints stated n the claim frm; e.g., "peridic headaches." Claims fr CT scans are reviewed fr evidence f abuse which might include the absence f reasnable indicatins fr the scans, an excessive number f scans r unnecessarily expensive types f scans cnsidering the facts in the particular cases. 1 NCD/NIA Heart CT & CT Cngenital Prprietary

2 NIA CLINICAL GUIDELINE FOR HEART CT AND HEART CT CONGENITAL: INTRODUCTION: Cardiac cmputed tmgraphy (Heart CT) can be used t image the cardiac chambers, valves, mycardium and pericardium t assess cardiac structure and functin. Applicatins f Heart CT listed and discussed in this guideline include: characterizatin f cngenital heart disease, characterizatin f cardiac masses, diagnsis f pericardial diseases, and preperative crnary vein mapping. The table belw crrelates and matches the clinical indicatins with the Apprpriate Use Scre based n a scale f 4 t 9, where the upper range (7 t 9) implies that the test is generally acceptable and is a reasnable apprach. The mid-range (4 t 6) indicates uncertainty in the apprpriateness f the test fr the clinical scenari. In all cases, additinal factrs shuld be taken int accunt including but nt limited t cst f test, impact f the image n clinical decisin making when cmbined with clinical judgment and risks, such as radiatin expsure and cntrast adverse effects, shuld be cnsidered. Where the Heart CT is the preferred test based upn the indicatin the Apprpriate Use Scre will be in the upper range such as nted with indicatin #51 assessment f right ventricular mrphlgy r suspected arrhythmgenic right ventricular dysplasia. Fr indicatins in which there are ne r mre alternative tests with an apprpriate use scre rating (apprpriate, uncertain) nted, fr example indicatin #52 (Assessment f mycardial viability, prir t mycardial revascularizatin fr ischemic left ventricular systlic dysfunctin and ther imaging mdalities are inadequate r cntraindicated), additinal factrs shuld be cnsidered when determining the preferred test (Stress Echcardigram if there are n cntra-indicatins). Where indicated as alternative tests, TTE (transthracic echcardigraphy) and SE (Stress echcardigraphy) are a better chice, where pssible, because f avidance f radiatin expsure. Heart MRI can be cnsidered as an alternative, especially in yung patients, where recurrent examinatins may be necessary. 2 NCD/NIA Heart CT & CT Cngenital Prprietary

3 INDICATIONS FOR HEART CT: T qualify fr cardiac cmputed tmgraphy, the patient must meet ACCF/ASNC Apprpriateness Use Scre (Apprpriate Use Scre 7 9 r Uncertain Apprpriate Use Scre 4-6). ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Apprpriate Use Criteria fr Cardiac (Heart) Cmputed Tmgraphy: ACCF et al. Criteria # Heart CT (Indicatin and Apprpriate Use Scre) A= Apprpriate; U=Uncertain 46 A (9) 47 A (8) 48 A (7) 50 A (7) 51 A (7) 52 U (5) INDICATIONS (*Refer t Additinal Infrmatin sectin) Evaluatin f Cardiac Structure and Functin Adult Cngenital Heart Disease Assessment f anmalies f crnary arterial and ther thracic arterivenus vessels ( fr anmalies f crnary arterial vessels CCTA preferred and fr ther thracic arterivenus vessels Heart CT preferred ) Further assessment f cmplex adult cngenital heart disease after cnfirmatin by TTE echcardigram Other imaging mdality crsswalk, TTE, Stress Ech (SE) and Heart MRI (ACCF et.al. Criteria # Indicatin with Apprpriate Use Scre TTE 92 and 94 A (9) Evaluatin f Ventricular Mrphlgy and Systlic Functin Evaluatin f left ventricular functin Fllwing acute MI r in HF patients Inadequate images frm ther nninvasive methds Quantitative evaluatin f right ventricular functin Assessment f right ventricular mrphlgy Suspected arrhythmgenic right ventricular dysplasia Assessment f mycardial viability Prir t mycardial revascularizatin fr ischemic left TTE 15 A(9) SE 176 A(8) 3 NCD/NIA Heart CT & CT Cngenital Prprietary

4 ACCF et al. Criteria # Heart CT (Indicatin and Apprpriate Use Scre) A= Apprpriate; U=Uncertain INDICATIONS (*Refer t Additinal Infrmatin sectin) ventricular systlic dysfunctin Other imaging mdalities are inadequate r cntraindicated Evaluatin f Intra- and Extracardiac Structures Characterizatin f native cardiac valves Suspected clinically significant 53 A (8) valvular dysfunctin Inadequate images frm ther nninvasive methds Characterizatin f prsthetic cardiac valves Suspected clinically significant 54 A (8) valvular dysfunctin Inadequate images frm ther nninvasive methds Evaluatin f cardiac mass (suspected tumr r thrmbus) 56 A (8) Inadequate images frm ther nninvasive methds 57 A (8) Evaluatin f pericardial anatmy 58 A (8) 59 A (8) 60 A (8) Evaluatin f pulmnary vein anatmy Prir t radifrequency ablatin fr atrial fibrillatin Nninvasive crnary vein mapping Prir t placement f biventricular pacemaker Lcalizatin f crnary bypass grafts and ther retrsternal anatmy Prir t preperative chest r cardiac surgery ( fr lcalizatin f crnary bypass grafts CCTA preferred and fr ther retrsternal anatmy Heart CT preferred ) Other imaging mdality crsswalk, TTE, Stress Ech (SE) and Heart MRI (ACCF et.al. Criteria # Indicatin with Apprpriate Use Scre Heart MRI 23 A(8) Heart MRI 23 A(8) Heart MRI 26 A(9) 4 NCD/NIA Heart CT & CT Cngenital Prprietary

5 Fr indicatins in which there are ne r mre alternative tests with an apprpriate use scre rating (apprpriate, uncertain) nted, (fr example indicatin #52) then additinal factrs shuld be cnsidered when determining the preferred test (Stress Echcardigram if there are n cntraindicatins). Indicatin #52 f Heart CT: Assessment f mycardial viability Prir t mycardial revascularizatin fr ischemic left ventricular systlic dysfunctin Other imaging mdalities are inadequate r cntraindicated General Cntraindicatins t the Stress Ech: Inability t exercise, Obesity with a BMI equal t r greater than 40 Stress echcardigraphy has been perfrmed hwever findings were inadequate, there were technical difficulties with interpretatin, r results were discrdant with previus clinical data. Arrhythmias with Stress Echcardigraphy - any patient n a type 1C antiarrhythmic drug (i.e. Flecainide r Prpafenne) r cnsidered fr treatment with a type 1C anti-arrhythmic drug. Fr all ther requests, the patient must meet ACCF/ASNC Apprpriateness criteria fr indicatins (scre 4-9) abve. INDICATIONS IN ACC GUIDELINES WITH INAPPROPRIATE DESIGNATION: Patient meets ACCF/ASNC Apprpriateness Use Scre fr inapprpriate indicatins (median scre 1-3) nted belw OR ne r mre f the fllwing: Fr same imaging tests less than six weeks apart unless specific guideline criteria states therwise. Fr different imaging tests, such as CT and MRI, f same anatmical structure less than six weeks apart withut high level review t evaluate fr medical necessity. Fr re-imaging f repeat r pr quality studies. Fr imaging f pediatric patients twelve years ld and yunger under prspective authrizatins. Cntraindicatins - There is insufficient data t supprt the rutine use f Heart CT fr the fllwing: As the first test in evaluating symptmatic patients (e.g. chest pain) T evaluate chest pain in an intermediate r high risk patient when a stress test (exercise treadmill, stress ech, MPI, cardiac MRI, cardiac PET) is clearly psitive r negative. Preperative assessment fr nn-cardiac, nnvascular surgery Preperative imaging prir t rbtic surgery (e.g. t visualize the entire arta) Evaluatin f left ventricular functin fllwing mycardial infarctin r in chrnic heart failure. 5 NCD/NIA Heart CT & CT Cngenital Prprietary

6 Mycardial perfusin and viability studies. Evaluatin f patients with pstperative native r prsthetic cardiac valves wh have technically limited echcardigrams, MRI r TEE. ADDITIONAL INFORMATION RELATED TO HEART CT: Abbreviatins ACS = acute crnary syndrme ARVC = arrhythmgenic cardimypathy ARVD = arrhythmgenic right ventricular dysplasia CABG = crnary artery bypass grafting surgery CAD = crnary artery disease CCS = crnary calcium scre CHD = crnary heart disease CT = cmputed tmgraphy CTA = cmputed tmgraphy angigraphy ECG = electrcardigram HF = heart failure MET = estimated metablic equivalent f exercise MI = mycardial infarctin MPI = Mycardial Perfusin Imaging r Nuclear Cardiac Imaging PCI = percutaneus crnary interventin SE = Stress Echcardigram TTE = Transthracic Echcardigraphy ECG Uninterpretable Refers t ECGs with resting ST-segment depressin ( 0.10 mv), cmplete LBBB, preexcitatin (Wlff-Parkinsn-White Syndrme), r paced rhythm. Acute Crnary Syndrme (ACS): Patients with an ACS include thse whse clinical presentatins cver the fllwing range f diagnses: unstable angina, mycardial infarctin withut ST-segment elevatin (NSTEMI), and mycardial infarctin with ST-segment elevatin (STEMI) *Pretest Prbability f CAD fr Symptmatic (Ischemic Equivalent) Patients: Typical Angina (Definite): Defined as 1) substernal chest pain r discmfrt that is 2) prvked by exertin r emtinal stress and 3) relieved by rest and/r nitrglycerin. Atypical Angina (Prbable): Chest pain r discmfrt that lacks 1 f the characteristics f definite r typical angina. Nnanginal Chest Pain: Chest pain r discmfrt that meets 1 r nne f the typical angina characteristics. Once the presence f symptms (Typical Angina/Atypical Angina/Nn angina chest pain/asymptmatic) is determined, the pretest prbabilities f CAD can be calculated frm the risk algrithms as fllws: 6 NCD/NIA Heart CT & CT Cngenital Prprietary

7 Age (Years) < >60 Gender Typical/Definite Angina Pectris Atypical/Prbabl e Angina Pectris Nnanginal Chest Pain Asymptmatic Men Intermediate Intermediate Lw Very lw Wmen Intermediate Very lw Very lw Very lw Men High Intermediate Intermediate Lw Wmen Intermediate Lw Very lw Very lw Men High Intermediate Intermediate Lw Wmen Intermediate Intermediate Lw Very lw Men High Intermediate Intermediate Lw Wmen High Intermediate Intermediate Lw Very lw: Less than 5% pretest prbability f CAD Lw: Less than 10% pretest prbability f CAD Intermediate: Between 10% and 90% pretest prbability f CAD High: Greater than 90% pretest prbability f CAD **Glbal CAD Risk: It is assumed that clinicians will use current standard methds f glbal risk assessment such as thse presented in the Natinal Heart, Lung, and Bld Institute reprt n Detectin, Evaluatin, and Treatment f High Bld Chlesterl in Adults (Adult Treatment Panel III [ATP III]) (18) r similar natinal guidelines. CAD risk refers t 10- year risk fr any hard cardiac event (e.g., mycardial infarctin r CAD death). Lw glbal CAD risk Defined by the age-specific risk level that is belw average. In general, lw risk will crrelate with a 10-year abslute CAD risk <10%. Hwever, in wmen and yunger men, lw risk may crrelate with 10-year abslute CAD risk <6%. Intermediate glbal CAD risk Defined by the age-specific risk level that is average. In general, mderate risk will crrelate with a 10-year abslute CAD risk range f 10% t 20%. Amng wmen and yunger age men, an expanded intermediate risk range f 6% t 20% may be apprpriate. High glbal CAD risk Defined by the age-specific risk level that is abve average. In general, high risk will crrelate with a 10-year abslute CAD risk f >20%. CAD equivalents (e.g., diabetes mellitus, peripheral arterial disease) can als define high risk. Periperative Clinical Risk Predictrs: Histry f ischemic heart disease Histry f cmpensated r prir heart failure Histry if cerebrvascular disease Diabetes mellitus (requiring insulin) Renal insufficiency (creatinine >2.0) 7 NCD/NIA Heart CT & CT Cngenital Prprietary

8 Surgical Risk Categries (As defined by the ACC/AHA Guideline Update fr Periperative Cardivascular Evaluatin f Nn-Cardiac Surgery) High-Risk Surgery cardiac death r MI greater than 5% Emergent majr peratins (particularly in the elderly), artic and peripheral vascular surgery, prlnged surgical prcedures assciated with large fluid shifts and/r bld lss. Intermediate-Risk Surgery cardiac death r MI = 1% t 5% Cartid endarterectmy, head and neck surgery, surgery f the chest r abdmen, rthpedic surgery, prstate surgery. Lw-Risk Surgery cardiac death r MI less than 1% Endscpic prcedures, superficial prcedures, cataract surgery, breast surgery. Request fr a fllw-up study - A fllw-up study may be needed t help evaluate a patient s prgress after treatment, prcedure, interventin r surgery. Dcumentatin requires a medical reasn that clearly indicates why additinal imaging is needed fr the type and area(s) requested. Echcardigraphy This study remains the best test fr initially examining children in the assessment f cngenital heart disease. Hwever, if findings are unclear r need cnfirmatin, CT is useful and can ften be perfrmed with nly mild sedatin because f the shrt acquisitin time. CT and Cngenital Heart Disease (CHD) Many mre children with cngenital heart disease (CHD) are surviving t adulthd, increasing the need fr specialized care and sphisticated imaging. Currently mre adults than children have CHD. CT prvides 3D anatmic relatinship f the bld vessels and chest wall, and depicts cardivascular anatmic structures. It is used in the evaluatin f cngenital heart disease in adults, e.g., ventricular septal defect and anmalies f the artic valve. CT is als used increasingly in the evaluatin f patients with chest pain, resulting in detectin f unsuspected cngenital heart disease. CT is useful in the evaluatin f children with CHD when findings frm echcardigraphy are unclear r need cnfirmatin. CT and Cardiac Masses CT is used t evaluate cardiac masses, describing their size, density and spatial relatinship t adjacent structures. Nearly all cardiac tumrs are metastases. Primary tumrs f the heart are rare and mst are benign. Cardiac myxma is the mst cmmn type f primary heart tumr in adults and usually develps in the left atrium. Characteristic features f myxmas that can be assessed accurately n CT include lcatin in the left atrium, lbulated margin, inhmgeneus cntent, and a CT attenuatin value lwer that that f bld. Echcardigraphy is the methd f chice fr the diagnsis f cardiac myxma; CT is used t evaluate a patient with suspected myxma befre surgery. Cardiac tumrs generally vary in their mrphlgy and CT assessment may be limited. MRI may be needed fr further evaluatin. CT and Pericardial Disease CT is used in the evaluatin f pericardial cnditins. Echcardigraphy is mst ften used in the initial examinatin f pericardial disease, but has disadvantages when cmpared with CT which prvides a larger field f view than echcardigraphy. CT als has superir sft-tissue cntrast and prvides anatmic delineatins enabling lcalizatin f pericardial masses. Cntrast-enhanced CT is sensitive 8 NCD/NIA Heart CT & CT Cngenital Prprietary

9 in differentiating restrictive cardimypathy frm cnstrictive pericarditis which is caused mst ften by cardiac surgery and radiatin therapy. CT can depict thickening and calcificatin f the pericardium, which alng with symptms f physilgic cnstrictin r restrictin, may indicate cnstrictive pericarditis. CT is als used in the evaluatin f pericardial masses which are ften detected initially with echcardigraphy. CT can accurately define the site and extent f masses, e.g., cysts, hematmas and neplasms. CT and Radifrequency Ablatin fr Atrial Fibrillatin Atrial fibrillatin, an abnrmal heart rhythm riginating in the atria, is the mst cmmn supraventricular arrhythmia in the United States and can be a cause f mrbidity. In patients with atrial fibrillatin, radifrequency ablatin is used t electrically discnnect the pulmnary veins frm the left atrium. Prir t this prcedure, CT may be used t define the pulmnary venus anatmy which is cmmnly variable. Determinatin f hw many pulmnary veins are present and their stial lcatins is imprtant t make sure that all the stia are ablated. 9 NCD/NIA Heart CT & CT Cngenital Prprietary

10 REFERENCES ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Apprpriate Use Criteria fr Cardiac Cmputed Tmgraphy: A Reprt f the American Cllege f Cardilgy Fundatin Apprpriate Use Criteria Task Frce, the Sciety f Cardivascular Cmputed Tmgraphy, the American Cllege f Radilgy, the American Heart Assciatin, the American Sciety f Echcardigraphy, the American Sciety f Nuclear Cardilgy, the Nrth American Sciety fr Cardivascular Imaging, the Sciety fr Cardivascular Angigraphy and Interventins, and the Sciety fr Cardivascular Magnetic Resnance. J. Am. Cll. Cardil. 56, Retrieved frm ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Apprpriate Use Criteria fr Echcardigraphy. A Reprt f the American Cllege f Cardilgy Fundatin Apprpriate Use Criteria Task Frce, American Sciety f Echcardigraphy, American Heart Assciatin, American Sciety f Nuclear Cardilgy, Heart Failure Sciety f America, Heart Rhythm Sciety, Sciety fr Cardivascular Angigraphy and Interventins, Sciety f Critical Care Medicine, Sciety f Cardivascular Cmputed Tmgraphy, and Sciety fr Cardivascular Magnetic Resnance. Endrsed by the American Cllege f Chest Physicians. J Am Cll Cardil. Retrieved frm ACC/AHA/AATS/PCNA/SCAI/STS 2014 Fcused Update f the Guideline fr the Diagnsis and Management f Patients With Stable Ischemic Heart DiseaseA Reprt f the American Cllege f Cardilgy/American Heart Assciatin Task Frce n Practice Guidelines, and the American Assciatin fr Thracic Surgery, Preventive Cardivascular Nurses Assciatin, Sciety fr Cardivascular Angigraphy and Interventins, and Sciety f Thracic Surgens. Jurnal f the American Cllege f Cardilgy, 2014, 7, di: /j.jacc Retrieved frm ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimdality Apprpriate Use Criteria fr the Detectin and Risk Assessment f Stable Ischemic Heart DiseaseA Reprt f the American Cllege f Cardilgy Fundatin Apprpriate Use Criteria Task Frce, American Heart Assciatin, American Sciety f Echcardigraphy, American Sciety f Nuclear Cardilgy, Heart Failure Sciety f America, Heart Rhythm Sciety, Sciety fr Cardivascular Angigraphy and Interventins, Sciety f Cardivascular Cmputed Tmgraphy, Sciety fr Cardivascular Magnetic Resnance, and Sciety f Thracic Surgens. Jurnal f the American Cllege f Cardilgy, 2014, 63(4), di: /j.jacc Retrieved frm American Cllege f Radilgy. (2014). ACR Apprpriateness Criteria Retrieved frm Crnin, P., Sneider, M. B., Kazerni, E.A., Kelly, A. M., Scharf, C., Oral, H., & Mrady, F. (2004, September). MDCT f the left atrium and pulmnary veins in planning 10 NCD/NIA Heart CT & CT Cngenital Prprietary

11 radifrequency ablatin fr atrial fibrillatin: a hw-t guide. Am J Rentgenl, 183(3), Retrieved frm Einstein, A. (2012). Effects f radiatin expsure frm cardiac imaging: hw gd are the data? Jurnal f the American Cllege f Cardilgy, 59(6), Retrieved frm Frauenfelder, T., Appenzeller, P., Karl, C., Scheffel, H., Desbilles, L., Stlzmann, P.,... Schertier, T. (2011). Triple rule-ut CT in the emergency department: prtcls and spectrum f imaging findings. Eurpean Radilgy, 19(4), Retrieved frm Jngbled, M. R., Dirksen, M.S., Bax, J. J., Bersma, E., Geleijns, K., Lamb, H. J.,... Schalij, M. J. (2005, March). Atrial fibrillatin: Multi-detectr rw CT f pulmnary vein anatmy prir t radifrequency catheter ablatin--initial experience. Radilgy, 234(3), Retrieved frm Naplitan, G., Pressacc, J., & Paquet, E. (2009, February). Imaging features f cnstrictive pericarditis: beynd pericardial thickening. Canadian Assciatin f Radilgists Jurnal, 60(1), Retrieved frm Schenhagen, P., Halliburtn, S. S., Stillman, A. R., & White, R. D. (2005, February). CT f the heart: principles, advances, clinical uses. Cleveland Clinic Jurnal f Medicine, 72(2), Retrieved frm Sctt-Mncrieff, A., Yang, J., Levine, D., Taylr, C., Ts, D., Jhnsn, M.,... Leipsic, J. (2011). Real-wrld estimated effective radiatin dses frm cmmnly used cardiac testing and prcedural mdalities. The Canadian Jurnal f Cardilgy, 27(5), Retrieved frm timated_effective_radiatin_dses_frm_cmmnly_used_cardiac_testing_and_prcedur al_mdalities_ Tatli, S., & Liptn, M. J. (2005, February). CT fr intracardiac thrmbi and tumrs. Internatinal Jurnal f Cardivascular Imaging, 21(1), di: /s x. Techasith, T., & Cury, R. (2011). Stress mycardial CT perfusin: an update and future perspective. JACC. Cardivascular Imaging, 4(8), Retrieved frm Van de Veire, N. R., Schuijf, J. D., De Sutter, J., Devs, D., Bleeker, G. B., de Rs, A., Bax, J. J. (2006, Nv). Nn-invasive visualizatin f the cardiac venus system in crnary artery disease patients using 64-slice cmputed tmgraphy. Jurnal f the American Cllege f Cardilgy, 48(9), Retreived frm di.rg/ /j.jacc NCD/NIA Heart CT & CT Cngenital Prprietary

12 Wang, Z. J., Reddy, G., Gtway, M. B., Yeh, B. M., Hetts, S. W., & Higgins, C. B. (2003, Octber). CT and MR imaging f pericardial disease. Radigraphics, 23, S167-S180. Retrieved frm Wiant, A., Nyberg, E., Gilkesn, R. C. (2009, August). CT evaluatin f cngenital heart disease in adults. Am J Rentgenl, 193(2), Retrieved frm 12 NCD/NIA Heart CT & CT Cngenital Prprietary

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY:

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR COMPUTED TOMOGRAPHY: Natinal Imaging Assciates, Inc. Clinical guideline: CT CORONARY ANGIOGRAPHY (CCTA) Original Date: Octber 6, 2009 Page 1 f 13 CPT Cdes: 75574 Last Reviewed Date: September 2014 NCD 220.1 Last Effective

More information

National Imaging Associates, Inc. Clinical guideline:

National Imaging Associates, Inc. Clinical guideline: Natinal Imaging Assciates, Inc. Clinical guideline: Original Date: Octber 6, 2009 CT CORONARY ANGIOGRAPHY () Page 1 f 14 CPT Cdes: 75574 Last Reviewed Date: July 2013 Guideline Number: NIA_CG_062 Last

More information

Original Date: March 26, 2008 HEART MRI. Guideline Number: NIA_CG_028 Last Revised Date: September 2011 Responsible Department: Clinical Operations

Original Date: March 26, 2008 HEART MRI. Guideline Number: NIA_CG_028 Last Revised Date: September 2011 Responsible Department: Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines Original Date: March 26, 2008 HEART MRI Page 1 f 11 CPT Cdes: 75557, 75559, 75561, 75563 Last Review Date: September 2014 +75565 Guideline Number: NIA_CG_028

More information

Original Date: July 1999 HEART (Cardiac) PET

Original Date: July 1999 HEART (Cardiac) PET Natinal Imaging Assciates, Inc. Clinical guidelines Original Date: July 1999 HEART (Cardiac) PET Page 1 f 10 CPT Cdes: 78459, 78491, 78492 Last Reviewed Date: September 2015 Guideline Number: NIA_CG_072

More information

Original Date: July 1999 HEART (Cardiac) PET

Original Date: July 1999 HEART (Cardiac) PET Magellan Healthcare Clinical guidelines Original Date: July 1999 HEART (Cardiac) PET Page 1 f 10 CPT Cdes: 78459, 78491, 78492, +0482T Last Reviewed Date: March, 2017 Guideline Number: NIA_CG_072 Last

More information

Original Date: March 26, 2008 HEART MRI

Original Date: March 26, 2008 HEART MRI Magellan Healthcare Clinical guidelines Original Date: March 26, 2008 HEART MRI Page 1 f 21 CPT Cdes: 75557, 75559, 75561, 75563 Last Review Date: August 2016 +75565 NCD 220.2 MRI Last Effective Date:

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

Echocardiography Diagnostic Accuracy

Echocardiography Diagnostic Accuracy Echcardigraphy Diagnstic Accuracy Measure Descriptin: The prprtin f ptentially preventable and clinically imprtant inaccurate diagnses amng cngenital heart surgical patients. Numeratr Number f cngenital

More information

Original Date: February, 2013 PACEMAKER

Original Date: February, 2013 PACEMAKER Magellan Healthcare Clinical guidelines Original Date: February, 2013 PACEMAKER Page 1 f 9 CPT Cdes: Last Review Date: March 2017 33206, 33207, 33208, 33212, 33213, 33214, 33227, 33228 Guideline Number:

More information

Ischemic heart disease (angina/chest pain)

Ischemic heart disease (angina/chest pain) Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Vascular Imaging. EFFECTIVE JANUARY 1, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Vascular Imaging. EFFECTIVE JANUARY 1, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: Vascular Imaging EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Indications and Limitations of Coverage and/or Medical back to top

Indications and Limitations of Coverage and/or Medical back to top Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage

More information

TEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS

TEXAS-MAC - PART B-TRAILBLAZER TABLE OF CONTENTS TABLE OF CONTENTS CPT t LCD ID... 4 L26500- Autmatic Implantable Cardiac Defibrillatr (AICD) - 4C-58AB... 14 L26529- Cardiac Catheterizatin - 4C-50AB... 23 L26534- Transthracic Echcardigraphy (TTE) - 4C-52AB...

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

Emergency Department Performance Measures

Emergency Department Performance Measures Emergency Department Perfrmance Measures ACEP Clinical Emergency Data Registry () ACEP Campaign Centers fr Medicare and Medicaid Services (CMS) Medicare Beneficiary Quality Imprvement Prject (MBQIP) ED

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1 Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

2. How are screening and diagnostic mammograms different?

2. How are screening and diagnostic mammograms different? Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070) Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD

More information

ACRIN 6666 Screening Breast US Follow-up Assessment Form

ACRIN 6666 Screening Breast US Follow-up Assessment Form Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:

More information

SPECIALTY OF VASCULAR SURGERY Delineation of Clinical Privileges

SPECIALTY OF VASCULAR SURGERY Delineation of Clinical Privileges SPECIALTY OF VASCULAR SURGERY Delineatin f Clinical Privileges Criteria fr granting privileges: Current certificatin by the American Bard f Surgery, r the American Ostepathic Bard f Surgery, and subspecialty

More information

High Performance Network Quality Criteria for Designation

High Performance Network Quality Criteria for Designation Selected quality measures include: Specialty Measure Descriptin Allergy / Immunlgy Asthma Drug Mgt Vaccine Pneumnia Vaccine High Perfrmance Netwrk Quality Criteria fr Designatin AvMed has selected certain

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT DENERVATION (RADIOFREQUENCY NEUROLYSIS) CPT Cdes: Cervical Thracic Regin: 64633, +64634 Lumbar Sacral Regin: 64635, +64636

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

Specifically, on page 12 of the current evicore draft, we find the statement:

Specifically, on page 12 of the current evicore draft, we find the statement: Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in

More information

decreased when the man lies down. The varicocele cannot usually be palpated lying down.

decreased when the man lies down. The varicocele cannot usually be palpated lying down. Variccele - Management View full scenari Hw d I knw my patient has a variccele? The man may present with cncern abut scrtal swelling r scrtal pain, r a variccele may be an incidental finding n physical

More information

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin

More information

GENERAL / VASCULAR SONOGRAPHY OPTION COURSE OUTLINE AURORA ST. LUKE S MEDICAL CENTER SCHOOL OF DIAGNOSTIC MEDICAL SONOGRAPHY COURSE OVERVIEW

GENERAL / VASCULAR SONOGRAPHY OPTION COURSE OUTLINE AURORA ST. LUKE S MEDICAL CENTER SCHOOL OF DIAGNOSTIC MEDICAL SONOGRAPHY COURSE OVERVIEW AURORA ST. LUKE S MEDICAL CENTER SCHOOL OF DIAGNOSTIC MEDICAL SONOGRAPHY COURSE OVERVIEW The cre curriculum defines several majr mdules f ultrasund educatin. All lectures are crrelated with scan lab demnstratin

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit. Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure

More information

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation 8.03.08 Cardiac Rehabilitatin in the Outpatient Setting Sectin 8.0 Therapy Subsectin 8.03 Rehabilitatin Effective Date February 15, 2015 Original Plicy Date September 13, 1989 Next Review Date December

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

Clinical Orthopaedic Rehabilitation Spinal Disorders

Clinical Orthopaedic Rehabilitation Spinal Disorders COURSE DESCRIPTION Clinical Orthpaedic Rehabilitatin Spinal Disrders This prgram is a practical, clinical guide that prvides guidance n the evaluatin, differential diagnsis, treatment and rehabilitatin

More information

Fee Schedule - Home Health Care- 2015

Fee Schedule - Home Health Care- 2015 Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Imaging tests allow the cancer care team to check for cancer and other problems inside the body. IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral

More information

QUESTION 1. Year 2003 Paper two: Questions supplied by Tricia

QUESTION 1. Year 2003 Paper two: Questions supplied by Tricia QUESTION 1 A 65-year-ld wman presents with a ne-week histry f prgressive dyspnea. On admissin, there are signs f shck, a systlic murmur and an elevated jugular venus pressure. The ECG shws sinus tachycardia

More information

Chest Pain - Clinical Pathway: Emergency

Chest Pain - Clinical Pathway: Emergency Gals Decrease: Chest X-ray Lab testing Bedside cardilgy cnsultatin ECG Decrease ED LOS Imprve parental satisfactin Metrics General ED Length f stay Testing Lab testing Chest X-ray ECG Vlume/Cst Use f Order

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Updates to Medical Policies and Clinical UM Guidelines Effective January 15, 2012

Updates to Medical Policies and Clinical UM Guidelines Effective January 15, 2012 Updates t Medical Plicies and Clinical UM Guidelines Effective January 15, 2012 UniCare is pleased t prvide yu with ur updated and new medical plicies and clinical UM guidelines. The majr new new plicies

More information

INDICATIONS AND CONTRAINDICATIONS FOR PACEMAKERS BY CONDITION

INDICATIONS AND CONTRAINDICATIONS FOR PACEMAKERS BY CONDITION Natinal Imaging Assciates, Inc. Clinical guidelines CARDIAC RESYNCHRONIZATION THERAPY (CRT) CPT Cdes: 33221, 33224, 33225, 33229, 33231, 33264 Guideline Number: NIA_CG_320 Respnsible Department: Clinical

More information

Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014

Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014 Medical Plicy BSC8.01 Sectin 8.0 Therapy Subsectin Lifestyle Mdificatin Prgram fr Reversing Heart Disease Effective Date Nvember 26, 2014 Original Plicy Date Nvember 26, 2014 Next Review Date Nvember 2015

More information

EASTERN ARIZONA COLLEGE Advanced Cardiovascular Life Support

EASTERN ARIZONA COLLEGE Advanced Cardiovascular Life Support EASTERN ARIZONA COLLEGE Advanced Cardivascular Life Supprt Curse Design 2013-2014 Curse Infrmatin Divisin Allied Health Curse Number EMT 220 Title Advanced Cardivascular Life Supprt Credits 1 Develped

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

List the health concerns that brought you into this office

List the health concerns that brought you into this office New Practice Member Applicatin Name Date f Birth / / Age Male/Female Address City State Zip Cell Phne Hme Phne Cellular Prvider Email Address Occupatin Emplyer s Name Single / Married / Divrced / Widwed

More information

Guidelines, Policies and Statements D19 Statement on Visceral Vascular Testing Using Ultrasound

Guidelines, Policies and Statements D19 Statement on Visceral Vascular Testing Using Ultrasound Guidelines, Plicies and Statements D19 Statement n Visceral Vascular Testing Using Ultrasund Disclaimer and Cpyright The ASUM Standards f Practice Bard have made every effrt t ensure that this Guideline/Plicy/Statement

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Extremities. EFFECTIVE JANUARY 1, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Extremities. EFFECTIVE JANUARY 1, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Plicy Manual Effective Date: Octber 15, 2018 Related Plicies: Nne Wearable Cardiverter Defibrillatrs Descriptin A wearable cardiverter defibrillatr (WCD) is a temprary, external device that

More information

C-SAS.2 Small Animal Soft Tissue Surgery (A)

C-SAS.2 Small Animal Soft Tissue Surgery (A) C-SAS.2 Small Animal Sft Tissue Surgery (A) Credits: Prvider: 10 (100 hurs) Veterinary Pstgraduate Unit Schl f Veterinary Science RCVS Cntent Cvered The fllwing utlines the mdular cntent as set ut by the

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (2008) QUICK REFERENCE MARCH Supported by unrestricted educational grants from:

Nova Scotia Guidelines for Acute Coronary Syndromes (2008) QUICK REFERENCE MARCH Supported by unrestricted educational grants from: Nva Sctia Guidelines fr Acute Crnary Syndrmes (2008) QUICK REFERENCE MARCH 2010 Supprted by unrestricted educatinal grants frm: Critical Pathways STEMI in the Emergency department EVALUATION Vital Signs

More information

Measure Information Form

Measure Information Form Release Ntes: Measure Infrmatin Frm Versin 2.0 **NQF-ENDORSED VOLUNTRY CONSENSUS STNDRDS FOR HOSPITL CRE** Measure Set: Heart Failure (HF) Set Measure ID#: Measure Infrmatin Frm Perfrmance Measure Name:

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Chest. EFFECTIVE JANUARY 1, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Chest. EFFECTIVE JANUARY 1, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: Imaging f the Chest EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

The increase in life span of the American population over

The increase in life span of the American population over Ten-Year Experience f Cardiac Surgery in Patients Aged 80 Years and Over Tsung-P Tsai, MD, Aureli Chaux, MD, Jack M. Matlff, MD, Rbert M. Kass, MD, Richard J. Gray, MD, Michele A. DeRbertis, RN, and Steven

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Brain. EFFECTIVE JANUARY 1, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Brain. EFFECTIVE JANUARY 1, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: EFFECTIVE JANUARY 1, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Waterl Wellingtn Rehabilitative Care System Integrated Care Pathway fr STROKE Stream f Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Care Setting Activity Patients wh present t a cmmunity

More information

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Brain. EFFECTIVE MARCH 9, 2019 Proprietary

ADVANCED IMAGING CLINICAL APPROPRIATENESS GUIDELINES. Appropriate Use Criteria: Imaging of the Brain. EFFECTIVE MARCH 9, 2019 Proprietary CLINICAL APPROPRIATENESS GUIDELINES ADVANCED IMAGING Apprpriate Use Criteria: EFFECTIVE MARCH 9, 2019 Prprietary 8600 West Bryn Mawr Avenue Suth Twer Suite 800 Chicag, IL 60631 www.aimspecialtyhealth.cm

More information

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following: RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available

More information

Volume Measurement at CT

Volume Measurement at CT Vlume Measurement at CT Staging and Assessment f Respnse with Quantitative CT Lawrence Schwartz, MD Department f Radilgy Clumbia University Cllege f Physicians and Surgens LSCHWARTZ@COLUMBIA.EDU Recmmendatins

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)

Diabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring) Rule Categry: Medical ` Ref: N: 2013-MN-0012 Versin Cntrl: Versin N. 1.1 Effective Date: December 2013 Revisin Date: December 2014 Diabetes Mellitus Lab Tests (Screening, Diagnsis & Mnitring) Adjudicatin

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is

More information

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least

More information

Prostatitis - chronic - Management

Prostatitis - chronic - Management Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Noninvasive Peripheral Venous Studies

Noninvasive Peripheral Venous Studies Nninvasive Peripheral Venus Studies Nridian Healthcare Slutins, LLC Please Nte: This is a Prpsed LCD. Prpsed LCDs are wrks in prgress and nt necessarily a reflectin f the current plicies r practices. Prpsed

More information

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Rituxan (rituximab) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Effective Date: 10/01/2015 POLICY A. INDICATIONS The indicatins belw including FDA-apprved indicatins and cmpendial uses

More information

EASTERN ARIZONA COLLEGE Advanced Cardiac Life Support Renewal

EASTERN ARIZONA COLLEGE Advanced Cardiac Life Support Renewal EASTERN ARIZONA COLLEGE Advanced Cardiac Life Supprt Renewal Curse Design 2011-2012 Curse Infrmatin Divisin Allied Health Curse Number EMT 220A Title Advanced Cardiac Life Supprt Renewal Credits 0.5 Develped

More information